{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:47:37Z","timestamp":1787240857558,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"crossref","award":["24K12746"],"award-info":[{"award-number":["24K12746"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["24KJ1842"],"award-info":[{"award-number":["24KJ1842"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To identify optical coherence tomography-based imaging biomarkers that can localize focal leakage points without fluorescein angiography in central serous chorioretinopathy (CSC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective case\u2013control study analyzed 119 consecutive patients (123 eyes) with CSC between April 2018 and February 2024, comprising 66 eyes with focal-leakage type and 57 eyes with diffuse-leakage type. We assessed leakage sites using optical coherence tomography, and the proportions of optical coherence tomography findings were compared between focal-leakage and diffuse-leakage types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Hyporeflective lucency signs were observed in 27 eyes (40.9%) with focal-type CSC, while no such signs were detected in diffuse-type CSC cases (0.0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). In focal-type CSC, these signs were exclusively localized to leakage points, with no occurrence in other areas within serous retinal detachment. Microrips of retinal pigment epithelium and subretinal hyperreflective material were identified in 23 (34.8%) and 47 eyes (71.2%) with focal-type CSC, respectively, and also in eyes with diffuse-type CSC (5.3% and 19.3%, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 for both comparisons).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Only the hyporeflective lucency sign is present exclusively in focal leakage points of fluorescein angiography. Our findings suggested that the hyporeflective lucency sign may serve as a potential therapeutic target in CSC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004404","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:01:08Z","timestamp":1737561668000},"page":"893-900","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["IDENTIFICATION OF LEAKAGE SITES IN CENTRAL SEROUS CHORIORETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY AND THE ASSESSMENT OF THE CHARACTERISTICS OF THE BIOMARKERS"],"prefix":"10.1097","volume":"45","author":[{"given":"Ryoh","family":"Funatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Shiihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Imatsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250422","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"R2-20250422","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R3-20250422","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"R4-20250422","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","article-title":"Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan","volume":"106","author":"Kido","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R5-20250422","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"R6-20250422","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"R7-20250422","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bjophthalmol-2017-311338","article-title":"Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation","volume":"102","author":"Maltsev","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R8-20250422","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.2010.182121","article-title":"Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy","volume":"95","author":"Lim","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R9-20250422","doi-asserted-by":"crossref","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: an evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"R10-20250422","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.1016\/S0091-6749(18)30586-4","article-title":"Anaphylactoid reactions to fluorescein","volume":"101","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20250422","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2023.05.022","article-title":"Characteristics related to visual acuity loss after successful photodynamic therapy for eyes with central serous chorioretinopathy","volume":"256","author":"Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R13-20250422","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000484100","article-title":"Angiographic and tomographic prognostic factors of chronic central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"240","author":"Chung","year":"2018","journal-title":"Ophthalmologica"},{"key":"R14-20250422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE Trial Report No. 3","volume":"205","author":"van Rijssen","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R15-20250422","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"key":"R16-20250422","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R17-20250422","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1167\/iovs.12-10991","article-title":"Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy","volume":"54","author":"Yang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-20250422","doi-asserted-by":"crossref","first-page":"e193120","DOI":"10.1001\/jamaophthalmol.2019.3120","article-title":"Microrip of retinal pigment epithelium in central serous chorioretinopathy","volume":"138","author":"Ranjan","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R19-20250422","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2016.03.017","article-title":"Bullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imaging","volume":"123","author":"Balaratnasingam","year":"2016","journal-title":"Ophthalmology"},{"key":"R20-20250422","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ophtha.2008.01.021","article-title":"Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography","volume":"115","author":"Fujimoto","year":"2008","journal-title":"Ophthalmology"},{"key":"R21-20250422","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2024.04.025","article-title":"Pathogenesis of central serous chorioretinopathy and the link between choroidal hyperpermeability and retinal pigment epithelium pump reversal","volume":"266","author":"Fossataro","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"R22-20250422","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ophtha.2023.12.023","article-title":"Hyporeflective subretinal lucency in central serous chorioretinopathy","volume":"131","author":"Bijon","year":"2024","journal-title":"Ophthalmology"},{"key":"R23-20250422","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3928\/23258160-20150909-07","article-title":"A central hyporeflective subretinal lucency correlates with a region of focal leakage on fluorescein angiography in eyes with central serous chorioretinopathy","volume":"46","author":"Yannuzzi","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R24-20250422","doi-asserted-by":"crossref","first-page":"19505","DOI":"10.1038\/s41598-020-75789-w","article-title":"Quantitative measures of vortex veins in the posterior pole in eyes with pachychoroid spectrum diseases","volume":"10","author":"Matsumoto","year":"2020","journal-title":"Sci Rep"},{"key":"R25-20250422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"R26-20250422","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"R27-20250422","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R28-20250422","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10384-021-00861-5","article-title":"Clinical characteristics of central serous chorioretinopathy in patients by age","volume":"65","author":"Tanaka","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"R29-20250422","first-page":"279","article-title":"Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics","volume":"257","author":"Bae","year":"2019","journal-title":"Arbeitsphysiologie"},{"key":"R30-20250422","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1167\/iovs.09-4830","article-title":"Characterization of subretinal fluid leakage in central serous chorioretinopathy","volume":"51","author":"Pryds","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-20250422","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/eye.2009.193","article-title":"Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy","volume":"24","author":"Gupta","year":"2010","journal-title":"Eye (Lond)"},{"key":"R32-20250422","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"R33-20250422","doi-asserted-by":"crossref","first-page":"100201","DOI":"10.1016\/j.xops.2022.100201","article-title":"Natural course of pachychoroid pigment epitheliopathy","volume":"2","author":"Yagi","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"R34-20250422","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/eye.2015.208","article-title":"Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis","volume":"30","author":"Lu","year":"2016","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:00:43Z","timestamp":1745337643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004404","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}